Tech Transfer eNews Blog

Colorado State researchers rework a paper-based viral RNA test to diagnose COVID-19


By Jesse Schwartz
Published: July 22nd, 2020

Researchers at Colorado State University (CSU) have entered into a licensing agreement with Quara Devices to commercialize a viral RNA-testing platform to diagnose COVID-19.

The paper-based technology is able to detect small amounts of antibodies in a person’s blood. The researchers originally developed it to detect organisms with antimicrobial resistance. Later they realized they could generalize the technology into a sensitive test for RNA viruses, including coronaviruses such as SARS-CoV-2.

Quara Devices, which does business as Edoceo Devices, aims to use the technology to develop and commercialize a portable COVID-19 test.

“This technology predated the pandemic, but because of its versatility as a platform and the significant need for high accuracy in detecting COVID-19 in patients, we see an urgency to get it out now,” says Ken Reardon, professor at CSU and chief science officer at Edoceo. “We are trying to get this into the market within the year, which is a pretty aggressive acceleration.”

CSU Ventures, the university’s tech transfer arm, mediated the license agreement with Ecodeo. Todd Headley, president of CSU Ventures, says the university has seen around 20 technologies over the past several months in response to COVID-19.

“Researchers, as you can imagine, have really been honing in on helping to find solutions for a number of different issues out there,” Headley says. “Whether it’s personal protective equipment, or vaccines, or diagnostics, the university has been very active in pivoting a lot of the research into those areas.”

Source: Reporter Herald

Posted under: Tech Transfer e-News

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment